[go: up one dir, main page]

GB0606875D0 - Cytotrophoblast stem cells - Google Patents

Cytotrophoblast stem cells

Info

Publication number
GB0606875D0
GB0606875D0 GBGB0606875.3A GB0606875A GB0606875D0 GB 0606875 D0 GB0606875 D0 GB 0606875D0 GB 0606875 A GB0606875 A GB 0606875A GB 0606875 D0 GB0606875 D0 GB 0606875D0
Authority
GB
United Kingdom
Prior art keywords
stem cells
cytotrophoblast stem
cytotrophoblast
cells
stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0606875.3A
Other versions
GB2425129A (en
GB2425129B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axordia Ltd
Original Assignee
Axordia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axordia Ltd filed Critical Axordia Ltd
Publication of GB0606875D0 publication Critical patent/GB0606875D0/en
Publication of GB2425129A publication Critical patent/GB2425129A/en
Application granted granted Critical
Publication of GB2425129B publication Critical patent/GB2425129B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064Endothelial cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/119Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/31Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0606875A 2005-04-16 2006-04-06 Cytotrophoblast stem cell Expired - Fee Related GB2425129B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0507755.7A GB0507755D0 (en) 2005-04-16 2005-04-16 Cytotrophoblast stem cells

Publications (3)

Publication Number Publication Date
GB0606875D0 true GB0606875D0 (en) 2006-05-17
GB2425129A GB2425129A (en) 2006-10-18
GB2425129B GB2425129B (en) 2008-11-05

Family

ID=34630823

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0507755.7A Ceased GB0507755D0 (en) 2005-04-16 2005-04-16 Cytotrophoblast stem cells
GB0606875A Expired - Fee Related GB2425129B (en) 2005-04-16 2006-04-06 Cytotrophoblast stem cell

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0507755.7A Ceased GB0507755D0 (en) 2005-04-16 2005-04-16 Cytotrophoblast stem cells

Country Status (2)

Country Link
CN (1) CN101218342A (en)
GB (2) GB0507755D0 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103114075B (en) * 2013-01-18 2014-11-12 内蒙古大学 Cattle trophoderm stem cell system establishment method
JP6486948B2 (en) * 2014-01-08 2019-03-20 サムスン ライフ パブリック ウェルフェア ファウンデーション Stem cells derived from pure trophoblast layer and cell therapeutic agent containing the same
CN104946581B (en) * 2015-04-28 2017-10-13 广东温氏食品集团股份有限公司 A special medium and method for cultivating porcine trophoblast stem cells
CN111304156A (en) * 2020-02-20 2020-06-19 南方医科大学南方医院 Induced trophoblast stem cell and preparation method and application thereof
CN116286666B (en) * 2023-05-15 2023-08-04 成都云测医学生物技术有限公司 Trophoblast cell, preparation method and application thereof, and method for amplifying NK cell
CN119351312B (en) * 2024-12-19 2025-03-14 南京医科大学 Organoid capable of simulating uterine spiral arterial remodeling and in-vitro preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503320A (en) * 1995-04-07 1999-03-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア HLA-G detection antibody
WO2000017325A1 (en) * 1998-09-23 2000-03-30 Mount Sinai Hospital Trophoblast cell preparations
JP4264360B2 (en) * 2002-03-15 2009-05-13 ウィセル リサーチ インスティテュート インコーポレイテッド Production method of primate trophoblast
EP1812554A4 (en) * 2004-11-04 2008-10-08 Advanced Cell Tech Inc DERIVATION OF EMBRYONIC STEM CELLS
WO2006091766A2 (en) * 2005-02-24 2006-08-31 Jau-Nan Lee Human trophoblast stem cells and use thereof

Also Published As

Publication number Publication date
GB2425129A (en) 2006-10-18
GB0507755D0 (en) 2005-05-25
CN101218342A (en) 2008-07-09
GB2425129B (en) 2008-11-05

Similar Documents

Publication Publication Date Title
IL266958A (en) Placental stem cell populations
GB2441530B (en) Stem Cells
GB0709533D0 (en) Platelets from stem cells
GB0716233D0 (en) Valve
GB2437005B (en) Valve
GB2425129B (en) Cytotrophoblast stem cell
IL215527A (en) Immunoassay methods
GB0504156D0 (en) Valve
GB2429263B (en) Valve
GB0503918D0 (en) Cell
GB2429261B (en) Valve
GB0519657D0 (en) Valve
GB0511723D0 (en) Placental stem cells
GB0522564D0 (en) Cells
GB0500869D0 (en) Stem cells
GB0511918D0 (en) Valves
GB0521608D0 (en) Novel valve
GB0511433D0 (en) Valve
GB0500625D0 (en) Valve
GB0500624D0 (en) Valve
GB0500626D0 (en) Valve
GB0511435D0 (en) Valve
GB0522395D0 (en) Valve
ZA200508547B (en) Valve
PL374339A1 (en) Valve

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20110324 AND 20110330

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140406